Code: 6504 Abbreviation: CZ-CPA_2025_U4 Validity: 01.01.2025 - 09.09.9999 Family:
Correspondences: | ||
---|---|---|
Classification of Products (CZ-CPA_2025) - level 3 - Group | 211 | Basic pharmaceutical products |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21101 | Salicylic acid, O-acetylsalicylic acid, their salts and esters |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21102 | Lysine, glutamic acid and their salts; quaternary ammonium salts and hydroxides; phosphoaminolipids; amides and their derivatives and salts thereof |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21103 | Other lactones, heterocyclic compounds with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring, a pyrimidine ring, a piperazine ring, an unfused triazine ring or a phenothiazine ring system not further fused; hydantoin and its derivatives; sulphonamides |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21104 | Other sugars, chemically pure; other sugar ethers and esters and their salts |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21105 | Provitamins, vitamins and hormones; glycosides and vegetable alkaloids and their derivatives; antibiotics |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21106 | Glands and other organs; extracts thereof and other human or animal substances |
Classification of Products (CZ-CPA_2025) - level 5 - Category | 21109 | Sub-contracted operations as part of manufacturing of basic pharmaceutical products |